0001325812-15-000026.txt : 20150422
0001325812-15-000026.hdr.sgml : 20150422
20150422163934
ACCESSION NUMBER: 0001325812-15-000026
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150227
FILED AS OF DATE: 20150422
DATE AS OF CHANGE: 20150422
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Howton David T
CENTRAL INDEX KEY: 0001529297
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 15786054
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4/A
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4/A
2015-02-27
2015-03-03
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001529297
Howton David T
215 FIRST STREET, SUITE 7
CAMBRIDGE
MA
02142
0
1
0
0
SVP, General Counsel
Incentive Stock Option (right to buy)
13.9
2015-02-27
4
A
0
5993.0
0.0
A
2025-02-27
Common Stock
5993
5993
D
Non-Qualified Stock Option (right to buy)
13.9
2015-02-27
4
A
0
80007.0
0.0
A
2025-02-27
Common Stock
80007
80007
D
The total grant originally reported has not changed, however the Incentive Stock Option/Non-Qualified Stock Option split of this stock option was incorrectly stated in the reporting person's original Form 4.
25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant.
David Tyronne Howton
2015-04-22